To include your compound in the COVID-19 Resource Center, submit it here.

Veletri tezosentan: Phase II

Preliminary analysis of an international Phase II trial of 129 patients showed that Veletri at both 5 mg/hr and 25 mg/hr gave

Read the full 222 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE